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Evidence for new C-terminally truncated variants 
of α- and β-tubulins
ABSTRACT Cellular α-tubulin can bear various carboxy-terminal sequences: full-length tubu-
lin arising from gene neosynthesis is tyrosinated, and two truncated variants, corresponding 
to detyrosinated and Δ2 α-tubulin, result from the sequential cleavage of one or two C-termi-
nal residues, respectively. Here, by using a novel antibody named 3EG that is highly specific 
to the –EEEG C-terminal sequence, we demonstrate the occurrence in neuronal tissues of a 
new αΔ3-tubulin variant corresponding to α1A/B-tubulin deleted of its last three residues 
(EEY). αΔ3-tubulin has a specific distribution pattern: its quantity in the brain is similar to that 
of αΔ2-tubulin around birth but is much lower in adult tissue. This truncated α1A/B-tubulin 
variant can be generated from αΔ2-tubulin by the deglutamylases CCP1, CCP4, CCP5, and 
CCP6 but not by CCP2 and CCP3. Moreover, using 3EG antibody, we identify a C-terminally 
truncated β-tubulin form with the same –EEEG C-terminal sequence. Using mass spectrome-
try, we demonstrate that β2A/B-tubulin is modified by truncation of the four C-terminal resi-
dues (EDEA). We show that this newly identified βΔ4-tubulin is ubiquitously present in cells 
and tissues and that its level is constant throughout the cell cycle. These new C-terminally 
truncated α- and β-tubulin variants, both ending with –EEEG sequence, are expected to 
regulate microtubule physiology. Of interest, the αΔ3-tubulin seems to be related to dy-
namic microtubules, resembling tyrosinated-tubulin rather than the other truncated variants, 
and may have critical function(s) in neuronal development.
INTRODUCTION
Tubulin is subject to a large number of posttranslational modifica-
tions that are evolutionarily conserved. Most of these modifications 
generate chemical marks at the C-terminal tail of tubulin that project 
outside microtubules and might, by regulating interactions with pro-
tein partners, select microtubules for specific cellular functions 
(Janke and Bulinski, 2011). Among these modifications is the cycle 
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residue and some deglutamylases of the CCP family were shown to 
be able to cleave this residue in in vitro experiments (Berezniuk 
et al., 2012, 2013), we wondered whether a new variant correspond-
ing to α-tubulin truncated of three C-terminal amino acids (αΔ3-
tubulin) could exist in cells and tissues. We therefore developed an 
antibody against this putative form of α-tubulin, which we showed is 
highly specific to the –EEEG C-terminal sequence. Using this anti-
body, we demonstrated for the first time the occurrence of a Δ3 form 
of α1A/B-tubulin in the brain under physiological conditions. Our 
novel antibody also allowed us to identify a new β-tubulin variant 
ending with the same C-terminus as αΔ3-tubulin and corresponding 
to the C-terminally truncated β2A/B-tubulin, as demonstrated by 
mass spectrometry. Thus we showed that both α- and β-tubulin are 
broadly modified by C-terminal amino acid truncation.
RESULTS
3EG, a new antibody specific to the –EEEG C-terminal 
sequence
To study the possible occurrence of a new variant of α-tubulin 
missing its three C-terminal amino acids in cells and tissues, we 
developed polyclonal antibodies directed against peptide GE-
GEEEG, corresponding to the seven terminal amino acids of α1A/
B-tubulin without the EEY C-terminal tail. Sera from rabbits were 
tested for dilution and specificity by both Western blotting and 
immunocytochemistry.
The new antibodies (called 3EG), together with anti–tyrosinated 
α-tubulin (Wehland and Willingham, 1983), anti–detyrosinated α-
tubulin, and anti–Δ2α-tubulin (Paturle-Lafanechere et al., 1994) anti-
bodies, were tested by Western blots on extracts of HEK293T cells 
expressing different α-tubulins varying in their C-terminus and fused 
to mCherry at their N-terminus. Anti–total α-tubulin (αtot; Erck 
et al., 2005) was used as control of expressed mCherry–α-tubulins 
(95 kDa). As shown in Figure 1A (and quantified in Supplemental 
Table S1), each antibody is specific, and 3EG antibody is exclusively 
sensitive to αΔ3-tubulin. Faint bands are observed with anti-αTyr 
and anti-αΔ2 using extracts of cells expressing mCherry–αdeTyr-
tubulin. They are very probably the result of endogenous TTL or 
CCP, respectively, adding a tyrosine residue or cleaving a glutamate 
residue on the mCherry-tubulin.
To further characterize the sequence specificity of the 3EG anti-
body, we examined the effect of different epitope mutations, allow-
ing us to examine the reactivity of the antibody for the proteins from 
the seven α-tubulin genes (Figure 1B). Figure 1C illustrates that this 
novel antibody recognizes the four residues EEEG, with the glycine 
residue carrying the COOH. Changing the upstream glycine to a 
glutamate (using mCherry-αEEEEG) does not alter antibody reactiv-
ity. In contrast, modifying the two first glutamate residues of the 
EEEG motif leads to disappearance (as with mCherry-αGDDEG, 
-αGAEEG, and -αGENEG) or large reduction (as in the case of 
mCherry-αGEDEG) of staining. Figure 1B also shows that the C-
terminal residue has a major antigenic character. Indeed, the anti-
body does not stain α-tubulin ending with an alanine instead of a 
glycine residue (a mutation that chemically represents only a small 
change of the lateral chain).
We also tested the 3EG antibody in immunocytochemistry ex-
periments. We transfected fibroblasts with mCherry–αΔ3-tubulin 
and its mutated forms. We obtained comparable results to those 
observed by Western blot: 3EG was highly specific to fusion pro-
teins ending with EEEG (Figure 1D; not all mutations are shown). 
Nonetheless, the antibody gave no signal with mCherry–α-
GEDEG, in contrast to the slight staining obtained in the Western 
blot.
of tyrosine removal and re-addition at the C-terminus of α-tubulin 
and the further cleavage of the penultimate glutamate, leading to 
the formation of α-tubulin truncated of two C-terminal amino acids 
(αΔ2-tubulin; Paturle-Lafanechere et al., 1991). Another modifica-
tion that generates a huge variety of C-terminal tail versions is the 
enzymatic polyglutamylation of both α and β subunits. This modifi-
cation consists in addition of glutamate chains on the lateral chain of 
specific glutamate residues present in the primary sequences of the 
C-terminal region of tubulins (for review, see Janke and Bulinski, 
2011).
The cycle of detyrosination/tyrosination involves two enzymes: 
an unidentified peptidase (tubulin carboxypeptidase [TCP]) produc-
ing detyrosinated tubulin, and a ligase that re-adds the tyrosine 
(tubulin tyrosine ligase [TTL]). TTL was discovered in 1993 (Ersfeld 
et al., 1993) and shown to be essential for neuronal organization and 
tumor growth obstruction (Lafanechere et al., 1998; Erck et al., 
2005). Polyglutamylation is generated by two families of enzymes: 
the glutamylase family, which has nine TTL-like enzymes (Janke 
et al., 2005; van Dijk et al., 2007), and the deglutamylase family, 
which includes six cytosolic carboxpeptidases (CCPs; Rogowski 
et al., 2010; Moutin et al., 2011; Tort et al., 2014). Polyglutamylases 
differ in their preference for α- or β-tubulins and also for either side-
chain initiation or elongation. Deglutamylases can either remove 
the branch points of the glutamate side chains from the tubulin 
backbones or hydrolyze peptide bonds between glutamate resi-
dues of linear chains. Deglutamylases were also shown to cleave the 
C-terminal glutamate from detyrosinated tubulin to generate αΔ2-
tubulin (Rogowski et al., 2010; Tort et al., 2014).
The understanding of the molecular functions of each of these 
modifications in cells has progressed in recent years. The C-termi-
nal tyrosine of α-tubulin was shown to be crucial for positioning of 
CAP-Gly proteins at microtubule plus ends and essential for proper 
functioning of depolymerizing motors of the kinesin-13 family (Ba-
din-Larcon et al., 2004; Peris et al., 2006; 2009; Bieling et al., 2008). 
Detyrosinated tubulin has been shown to regulate the binding and 
motor activity of processive kinesin-1 in cells (Liao and Gundersen, 
1998; Dunn et al., 2008; Cai et al., 2009). An effect of microtubule 
detyrosination on processive motor functioning was also shown by 
in vitro experiments (Kaul et al., 2014; Sirajuddin et al., 2014). How-
ever, the regulation mechanism of this modification on motor trans-
port is controversial. No molecular role has been determined for 
αΔ2-tubulin. Because it accumulates in differentiated cells, it was 
proposed to irreversibly lock microtubules in a detyrosinated state, 
thus helping to permanently stabilize them (Paturle-Lafanechere 
et al., 1994). Polyglutamylation was shown to stimulate spastin-
mediated microtubule severing and thus to participate in regulat-
ing microtubule dynamics and stability (Lacroix et al., 2010). Con-
trolling the extent of polyglutamylation of tubulins is critical for 
neuron survival, as shown by studying pcd (Purkinje cell degenera-
tion) mice, which lacks functional CCP1 (Rogowski et al., 2010). In 
these mice, tubulin hyperglutamylation leads to massive degenera-
tion of particular neuron species.
In the brain, tubulins are very abundant and very heterogeneous, 
and this is essentially due to the presence of several tubulin isotypes 
arising from several genes and their polyglutamylation and detyros-
ination-linked modifications (Edde et al., 1990; Alexander et al., 
1991; Redeker et al., 1992, 1996, 1998; Redeker, 2010; Rudiger 
et al., 1992, 1995; Mary et al., 1994). Microtubules from neurons are 
known to carry elevated levels of polyglutamylated α- and β-tubulins 
(for review, see Janke and Bulinski, 2011), as well as high levels of 
detyrosinated and Δ2α-tubulin (Paturle-Lafanechere et al., 1994; 
Redeker et al., 1996). Because αΔ2-tubulin ends with a glutamate 
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different ages and from different brain struc-
tures. Among all tissues tested, αΔ3-tubulin 
is present only in the brain in both neonates 
(Figure 2A) and adults. Moreover, αΔ3-
tubulin is present in all brain regions ana-
lyzed (Supplemental Figure S1; neonate 
brain).
Surprisingly, in all tissues studied, we de-
tected another protein that also reacts with 
3EG antibody below the α-tubulin region, 
which thus does not correspond to αΔ3-
tubulin (Figure 2A). We characterized this 
other protein as β-tubulin, as will be shown 
later. In most of the following figures for 
αΔ3-tubulin, the lower, β-tubulin band is not 
shown.
Analysis of αΔ3-tubulin occurrence in 
different cell types, including fibroblasts, 
astrocytes, and neurons prepared from 
either the hippocampus or brain cortex, 
showed that αΔ3-tubulin is solely present in 
neurons (Figure 2B). We studied its amount 
in hippocampal neurons at different days of 
differentiation in vitro (DIV; Figure 2C), from 
3 to 21 DIV. We found that αΔ3-tubulin 
level was elevated from 3 to 14 DIV (corre-
sponding to the time of axogenesis and 
then dentritogenesis of these neuronal 
cells) and largely decreases at 21 DIV. In 
contrast, αΔ2-tubulin is more abundant in 
differentiated neurons, as already de-
scribed (Lafanechere and Job, 2000). We 
found that, in hippocampus neurons, the 
αΔ2-tubulin level significantly increases at 
14 DIV and is still much higher at 21 DIV, 
when spinogenesis occurs.
We examined the presence of αΔ3-
tubulin in the brain from embryonic day 13.5 
(E13.5) to adult. Figure 2D shows a typical 
Western blot, and Figure 2E shows the 
quantification of the blots. We find that αΔ3-
tubulin tends to have higher levels in the 
brain during embryonic stages and around 
birth and decreases later. In the adult brain, 
the level of αΔ3-tubulin is approximately 
three times lower than around birth. In con-
trast, the αΔ2-tubulin level increases in brain 
tissue throughout life, from the embryonic 
stage to adulthood. In the adult brain, the amount of αΔ2-tubulin is 
∼4 times the amount at birth and >10 times the amount at E13.5.
Status of the C-terminal truncations of the α-tubulin 
C-terminus in the brain
To further characterize α-tubulin species present in the brain, we 
quantified their distribution. Equal quantities of protein extracts 
from neonate and adult brains were subjected to immunoblot analy-
sis with antibodies recognizing either the unmodified C-terminal α-
tubulin tail (tyrosinated tubulin) or its processed versions (detyros-
inated, αΔ2-, or αΔ3-tubulin; Figure 2F). Extracts from HEK293T 
cells transfected with the corresponding forms of mCherry-α-tubulin 
were coanalyzed (Supplemental Figure S2). The αtot antibody was 
used for equal loading of brain extracts or of HEK293T extracts 
Taken together, our results show that the new antibody we devel-
oped is highly specific to –EEEG C-termini (and was therefore 
named 3EG) and can be used in Western blot and immunocyto-
chemistry experiments. Thus, although C-termini of α-tubulin genes 
share many amino acids, α1A/B, and to a lesser extent α4A, are the 
only ones stained by 3EG in Western blots, and only α1A/B is 
marked by 3EG in immunocytochemistry (Figure 1C). We thus used 
the 3EG antibody to examine by Western blot the possible occur-
rence of endogenous αΔ3-tubulins in mouse cells and tissues.
Evidence for αΔ3-tubulin in the brain and neurons
We prepared crude protein extracts from several organs of adult 
and neonate mice, including the brain, skeletal muscle, heart, kid-
ney, stomach, and spleen. We also extracted proteins from brains at 
FIGURE 1: A new antibody specific to the –EEEG protein C-terminus, named 3EG. 
(A, C) Immunoblot of protein extracts from HEK293T cells expressing different forms of 95-kDa 
α-tubulin fused to mCherry at their N-terminus. Expression levels were controlled with αtot 
antibody. Antibodies recognizing either the unmodified C-terminal α-tubulin tail (tyrosinated 
tubulin) or its processed versions (detyrosinated or Δ2- or Δ3-tubulin) were used in A, and 3EG 
antibody was used in C to assay mutation (gray) of the Δ3-tubulin epitope (red). Quantification 
of the data in A is presented in Supplemental Table S1. (B) Alignment of mouse α-tubulin 
C-termini. Epitope of αtot antibody in blue; conserved amino acids from the –EEEG C-terminal 
sequence in red. (D) Immunocytochemistry of MEFs transfected with mCherry–αΔ3-tubulin and 
a mutated form of this protein ending with EDEG instead of EEEG. Scale bar: 20 µm.
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FIGURE 2: αΔ3-Tubulin, a neuronal variant enriched around mouse birth. Equal quantities of proteins extracted from 
various tissues and cell types were subjected to immunoblot analysis. Protein levels were controlled using αtot antibody. 
(A) Immunoblot of crude protein extracts from the indicated neonate mouse tissues. (B) Immunoblot of protein extracts 
from the indicated cell types, including cortical and hippocampal neurons cultured 2 or 7 DIV. (C) Immunoblot of 
hippocampal neurons at different stages of culture. (D) Immunoblot of crude protein extracts from mouse brains at 
different stages of development, including E13.5 and E18.5, postnatal days 1, 8, 15 and 21 (P1–21), and adult (Ad). 
Mixes of four or five half-brains were used at each developmental stage. (E) Quantitative analysis of three immunoblots 
for αΔ3 and of five immunoblots for αΔ2 realized as in D with brain protein extracts. In each immunoblot, values 
obtained were normalized to the value obtained at P8. Error bars indicate SEM; a.u., arbitrary units. (F) Immunoblot of 
protein extracts from neonate (P1) and adult mouse brains (same extracts as in D). These samples were coanalyzed with 
extracts from HEK293T cells transfected with the various mCherry–α-tubulin variants (Supplemental Figure S2). 
(G) Quantitative analysis of immunoblots such as those presented in Supplemental Figure S2. Mixtures of five neonate 
brains and five adult half-brains were analyzed in two series of Western blots. The plotted values represent the 
percentages of the different forms of α-tubulin in brains estimated after normalization to total α-tubulin levels (with αtot 
antibody) and to antibody sensitivity (using modified mCherry–α-tubulins) as explained in Materials and Methods. 
(H) Immunoblot of crude protein extracts from wild-type (WT) and TTLL1-knockout mouse brains.
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fluorescence levels within cells expressing either CCP1 or CCP5 
(GFP-positive cells) compared with the level within cells that do not 
express the enzymes (GFP-negative cells). Both CCP1 and CCP5 
largely increase microtubule staining by 3EG antibody in TTL-knock-
out fibroblasts, reflecting their capacity to generate αΔ3-tubulin. 
However, these two enzymes differ in their ability to form αΔ2-
tubulin, as observed when studying their action on detyrosinated 
mCherry-tagged α-tubulin. Whereas CCP1 is able to process 
mCherry-deTyr-tubulin to generate the mCherry-αΔ2 variant, CCP5 
is not competent (Supplemental Figure S3)
On the basis of all of these data, we conclude that CCP1, CCP4, 
and CCP6 are able to form αΔ2-tubulin from detyrosinated tubulin 
(cleavage of E-E) and αΔ3-tubulin from αΔ2-tubulin (cleavage of 
G-E). Thus, unpredictably, these three enzymes are capable of cleav-
ing both E-E and G-E bonds. CCP2 and CCP3 are able to generate 
αΔ2-tubulin but seem incompetent to produce αΔ3-tubulin, and 
thus cleave E-E but not G-E bonds. CCP5, which is incompetent to 
cleave between two glutamates residues on the primary chain of 
α-tubulin to form αΔ2-tubulin, is efficient to cut between a glycine 
and a glutamate to generate αΔ3-tubulin from αΔ2-tubulin. Hence 
CCP2/3 and CCP5 seem to have different cleavage site preference 
(G-E vs. E-E), whereas CCP1/4/6 do not. Figure 3F summarizes 
these results.
We then wondered whether stabilizing microtubules could influ-
ence the generation of truncated variants and CCP activities as in 
the case of TCP. It is indeed well known that when living cells are 
incubated in the presence of the stabilizing drug paclitaxel, microtu-
bules become more detyrosinated due to the action of TCP 
(Wehland and Weber, 1987; Contin and Arce, 2000). Detyrosinated 
tubulin represents the initial substrate for αΔ3-tubulin formation by 
CCPs, being first transformed in αΔ2-tubulin and subsequently in 
αΔ3-tubulin. We examined the effect of stabilizing microtubules 
with paclitaxel on the formation of the truncated variant levels using 
wild-type and TTL-knockout fibroblasts, the latter already contain-
ing a high amount of αΔ2-tubulin. We found that although incuba-
tion with 15 μM paclitaxel for 2 h induced a significant increase of 
αdeTyr-tubulin in both types of cells, neither αΔ2-tubulin formation 
nor αΔ3-tubulin formation was observed (Figure 3B). We obtained 
comparable results when using HEK293T cells expressing CCP1 
subjected to the same drug treatment for 2 h (unpublished data). 
Thus, stabilizing microtubules for 2 h does not activate the CCP 
enzymes in charge of αΔ2- and αΔ3-tubulin formation, in contrast to 
what is observed with TCP. Given that activities of CCPs expressed 
in these cells are low (Rogowski et al., 2010), we then tested the ef-
fect of paclitaxel added for a long time at lower concentrations 
(50–200 nM) on HEK293T cells expressing CCP1. We added the 
drug 2 h after CCP1 transfection and for 24 h. In this latter case, we 
observed both an increase of αΔ2-tubulin and a decrease of αΔ3-
tubulin produced by the enzyme (Figure 3E, 50 nM paclitaxel). 
Hence generation of the truncated variants by CCP enzymes most 
probably relies on complex mechanisms related, at least in part, 
to microtubule dynamics. The reduction of these dynamics pro-
duces antagonistic effects on the generation of αΔ2-tubulin and 
αΔ3-tubulin.
β-Tubulin can be shortened at its C-terminus: evidence 
for ubiquitous βΔ4 variant
In all tissues (Figure 2A) or cells (Figure 4A) studied, we detected a 
protein band reacting with 3EG antibody just below the α-tubulin 
band, which thus does not correspond to αΔ3-tubulin. Migration of 
the two bands stained by the antibody is sensitive to the purity of 
the SDS used, as bands were effectively separated when less-pure 
expressing the mCherry-tagged α-tubulin variants. This experiment 
provides an estimate of the sensitivity of each tested antibody 
based on the immunoblot signal of the corresponding mCherry-
tagged variant (Supplemental Figure S2) and then allows the ap-
proximation of the quantity of each variant of α-tubulin in the ex-
tracts (Figure 2, F and G). We estimated that tyrosinated, 
detyrosinated, αΔ2-, and αΔ3-tubulin variants, respectively, corre-
spond to 69, 27, 2, and 1.3% of the total α-tubulin present in the 
neonate mouse brain. In adult brain tissue, α-tubulin variants were 
estimated as being divided into 25% tyrosinated, 45% detyros-
inated, 28% αΔ2, and 1% αΔ3 of the total α-tubulin.
Because tubulin polyglutamylation is high in the adult brain and 
occurs in the vicinity of the sequence recognized by the 3EG anti-
body, we wondered whether this might affect the 3EG signal. We 
thus quantified the amount of 3EG signal in TTLL1-knockout brain 
extracts, which exhibit very low levels of glutamylation (Janke et al., 
2005), and observed no difference from wild-type brain extracts 
(Figure 2H). In controls, the tubulin polyglytamylation revealed by 
the polyE antibody almost completely disappeared from TTLL1-
deficient extracts. Thus polyglutamylation does not alter 3EG anti-
body binding to tubulins.
Taken together, our results demonstrate the physiological occur-
rence of αΔ3-tubulin in brain tissue and particularly in neuronal cells. 
Although this pool of α-tubulin is not abundant, it is present in the 
brain and neurons at very specific stages. It is noteworthy that in 
the neonate brain, αΔ3-tubulin is present in a similar quantity to that 
of αΔ2-tubulin.
Specificity of deglutamylases involved in processing 
α-tubulin primary chain
Considering that deglutamylases from the CCP family catalyze re-
moval of glutamate side chains of α- and β-tubulins and also deglu-
tamylation of detyrosinated α-tubulin to form αΔ2 (Rogowski et al., 
2010; Tort et al., 2014), we tested their ability to produce the αΔ3-
tubulin variant. We analyzed protein extracts from HEK293T cells 
coexpressing mCherry-tagged αΔ2 tubulin and each of the CCPs. 
Results are presented in Figure 3A, with analysis of mCherry-tagged 
α-tubulin (95 kDa) on the left and examination of endogenous α-
tubulin (55 kDa) on the right. We find that CCP1, CCP4, CCP5, and 
CCP6 are competent to form αΔ3-tubulin from expressed mCherry–
αΔ2-tubulin (Figure 3A, left, row 2). In contrast, CCP2 and CCP3 
seem to lack this ability. As already described (Rogowski et al., 2010; 
Tort et al., 2014), all CCPs except CCP5 generate the αΔ2 variant 
from endogenous α-tubulin present in HEK293T cells (Figure 3A, 
right, top). Moreover, our data illustrate that only CCP1 and CCP6 
are sufficiently efficient to form αΔ3-tubulin from endogenous α-
tubulin (Figure 3A, right, row 2): these two enzymes sequentially 
remove the two glutamate residues from endogenous detyros-
inated tubulin, producing αΔ2- and then αΔ3-tubulin.
We also studied the activity of two of the deglutamylases, CCP1 
and CCP5, in generating the αΔ3 variant from αΔ2-tubulin by im-
munocytochemistry on fibroblasts from TTL-knockout mice. Com-
pared with wild type, fibroblasts isolated from TTL-knockout animals 
contain high levels of detyrosinated α-tubulin, as shown previously 
(Peris et al., 2006), and αΔ2-tubulin (Figure 3B). Hence they contain 
high amounts of substrate allowing αΔ3-tubulin formation. How-
ever, as in the wild-type fibroblasts (Figure 2B), the αΔ3-tubulin vari-
ant is not detected in the TTL-knockout fibroblasts (Figure 3B). 
Figure 3C shows that the expression of CCP5 (green fluorescent 
protein [GFP]–positive cells) induces an important increase in 3EG 
antibody labeling on microtubules (the same results were obtained 
with CCP1; unpublished data). Figure 3D shows an analysis of the 
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FIGURE 3: Specificity of CCP enzymes in producing αΔ2 and αΔ3. (A) Immunoblot of protein extracts from 
HEK293T cells coexpressing each GFP- or yellow fluorescent protein (YFP)–tagged CCP and mCherry–αΔ2-tubulin. 
Analysis of mCherry–α-tubulin (left) and endogenous α-tubulin (right). (B) Immunoblot of protein extracted from 
WT and TTL-knockout (TTL KO) fibroblasts after incubation with dimethyl sulfoxide (DMSO: control) or paclitaxel 
(15 µM) for 2 h. TTL KO cells contain high levels of detyrosinated and αΔ2-tubulin, but no αΔ3-tubulin is detected. 
The reactive 3EG band corresponds to β-tubulin (Figure 4). (C) Immunocytochemistry of TTL KO fibroblasts 
transfected with GFP-CCP5 and immunostained with anti–αTyr-tubulin and 3EG antibody. Scale bar: 20 µm. CCP5 
leads to the formation of αΔ3-tubulin. (D) Quantitative analysis of immunocytochemistry experiments as in C using 
TTL KO fibroblasts transfected with either GFP-CCP1 or GFP-CCP5. Fluorescence was measured as explained in 
Materials and Methods. (E) Immunoblot of protein extracted from HEK293T cells expressing GFP-CCP1 or not 
after incubation with DMSO (control) or paclitaxel (50 nM) for 24 h. (F) Schematic representation of the C-terminal 
amino acids of α1A/B-tubulin, 3EG epitope (red), and processing enzymes associated with the generation of the 
variants.
646 | C. Aillaud et al. Molecular Biology of the Cell
(αtot) and anti–β-tubulin (βtot) antibodies were done on crude pro-
tein extracts from HEK293T cells and neonate brains. The assays 
were performed in experimental conditions allowing separation of 
the tubulin monomers, in medium containing Tris buffer as in 
Giraudel et al. (1998). Results presented Figure 4B show that the 
protein present in the lower 3EG band from both extracts is immu-
noprecipitated by the anti–β-tubulin antibody, whereas the αΔ3 vari-
ant from brain extract is immunoprecipitated by αtot. As illustrated 
SDS was used. This well-known comportment of α- and β-tubulins 
from the tubulin dimer (Best et al., 1981) led us to suspect that the 
second protein stained by 3EG antibody could be β-tubulin. After 
purification of tubulins from adult and neonate brains by a cycle of 
microtubule assembly and disassembly, we found the same 3EG la-
beling, which strongly suggests that the two bands correspond to 
the two tubulin monomers (Supplemental Figure S4). To confirm our 
hypothesis, immunoprecipitation experiments with anti–α-tubulin 
FIGURE 4: Evidence for a ubiquitous truncated form of β-tubulin. (A) Immunoblot of crude extracts from the indicated 
mouse tissues (same experiment as Figure 2B, but with the lower protein bands included). Protein levels were controlled 
using αtot antibody. (B) Immunoprecipitation of endogenous α- and β-tubulins from HEK293T cells and neonate mouse 
brain using αtot (IP α) and βtot (IP β) antibodies and analysis with 3EG antibody. The quality of immunoprecipitations 
was controlled using αtot and βtot antibodies together with mouse TrueBlot secondary antibodies. (C) Alignment of 
C-termini from the eight mouse β-tubulin isotypes. The βtot antibody epitope is in blue, and the 3EG epitope is in red. 
(D) Identification of the C-terminal peptide of the truncated β2A/B-tubulin (ΔEDEA) from neonatal mouse brain. The 
MS/MS spectrum of the peptide ion with m/z = 649.24, corresponding to an experimental monoprotonated mass MH+ 
of 1296.4632 Da, is annotated. The b- and y-type fragments identified are indicated on the sequence of the C-terminal 
peptide DEQGEFEEEEG, with a theoretical mass MH+ of 1296.4630 Da. Loss of H2O and NH3 is labeled with asterisks 
and open dots, respectively.
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proving that the βΔ4-tubulin level is stable 
throughout the cell cycle.
Because the quantity of βΔ4-tubulin is 
not modified in HEK293T cells overexpress-
ing CCPs (Figure 5C), these enzymes are 
most probably not involved in the produc-
tion of the shortened β-tubulin variant.
Taken together, our data demonstrate 
for the first time the presence of a C-termi-
nally truncated variant of β-tubulin ubiqui-
tously distributed in cells and tissues 
(Figures 2A and 4A). This new form of tubu-
lin is attributed to the β2A/B-tubulin iso-
types and named βΔ4-tubulin.
Properties of the new truncated 
variants of tubulin in neurons
We examined the endogenous tubulin vari-
ants by immunofluorescence in cultured 
hippocampal neurons (2 DIV). Figure 6A il-
lustrates that the 3EG immunoreactivity for 
both αΔ3- and βΔ4-tubulin is present in the 
whole neuron. Moreover, we observe a 
strong correlation of 3EG immunoreactivity 
with αTyr staining but not with αdeTyr and 
αΔ2 staining (Supplemental Figure S6, A 
[growth cone magnification] and B [quantifi-
cation of modified-to-total α-tubulin ratio in 
the axon shaft and the growth cone]; this 
ratio changed between the axon and the 
growth cone when considering αdeTyr- and αΔ2-tubulins, but not 
when considering αΔ3- or αTyr-tubulins]). To assay the relationship 
between new tubulin variants and microtubule stability, we analyzed 
resistance to nocodazole of microtubules from the growth cone, 
which contains high levels of labile domains of tyrosinated microtu-
bules, as well as stable domains of detyrosinated microtubules 
(Baas et al., 1993; Brown et al., 1993). The ratio of each tubulin vari-
ant signal to total α-tubulin signal was measured over time after 
nocodazole treatment (15 μM). As predicted, nocodazole-resistant 
microtubules were largely enriched in αdeTyr-tubulin over time, 
whereas their content in αTyr-tubulin decreased (Figure 6B). Only 
slight changes in αΔ2 and 3EG (including αΔ3- and βΔ4-tubulin) 
signals were detected in nocodazole-resistant microtubules. Thus 
3EG-positive and αΔ2-positive microtubules seem to have moder-
ate stability in the growth cone of hippocampal neurons.
To distinguish αΔ3-tubulin and βΔ4-tubulin species, we then 
examined the endogenous variants by Western blots. Their distri-
bution between soluble and polymer pools was studied in 7 DIV 
hippocampus neurons in both the absence and presence of no-
codazole (Figure 6C). Acetylated-tubulin, a marker of highly stable 
micro tubules, was used as control. In the absence of nocodazole 
exposure, 97.4% of the signal for acetylated-tubulin was recovered 
in the microtubular fraction (Figure 6C, left). We found that αΔ3-
tubulin is clearly enriched within the microtubular fraction, like 
αdeTyr-tubulin and αΔ2-tubulin (88–92%). Of interest, the new β-
tubulin variant (βΔ4) was also principally retrieved within the poly-
mer pool (87.7 ± 2.1%, mean ± SEM, n = 3). In contrast, only 70% of 
αTyr-tubulin was found in the microtubular pool and 30% in the 
soluble one. On adding 20 μM nocodazole for 30 min, we observed 
a significant loss of neuronal microtubules (28%, as estimated from 
immunoblotting with αtot antibody) and clear changes in α-tubulin 
species distribution between soluble and microtubular pools 
Figure 4C, none of the β-tubulin isotypes encoded by the eight 
mouse genes contains an –EEEG sequence at its C-terminus. How-
ever, the sequence is present upstream within the C-terminal region 
of β2A/B-, β2C-, and β3-tubulin isotypes. To identify the β monomer 
subjected to C-terminal cleavage, we separated tubulins purified 
from neonate brains by SDS–PAGE. The protein band recognized 
by 3EG antibody and corresponding to β-tubulins was digested 
with AspN endoprotease. Peptides generated upon proteolysis 
were analyzed by mass spectrometry as described in Materials and 
Methods. We identified β1-, β2A/B-, and β3-tubulin isotypes in the 
mouse neonate brain, as previously observed in the rat neonate 
brain (Redeker, 2010). We detected the full-length C-termini of 
these three β-tubulin isotypes, predominantly nonglutamylated, but 
also monoglutamylated (β1, β2A/B, and β3) and biglutamylated 
(β2A/B and β3). By using a database of all possible truncated tubulin 
forms, we unambiguously identified a C-terminal peptide of the 
β2A/B-tubulin missing the four last amino acids, –EDEA (Figure 4D), 
named βΔ4-tubulin, which terminates with –EEEG residues and 
presents the epitope recognized by the 3EG antibody. This peptide 
was predominantly nonglutamylated, but a low-abundance mono-
glutamylated form was also identified by mass spectrometry. No 
other truncated C-terminal peptide of β-tubulin was detected.
We then used 3EG antibody in immunofluorescence experi-
ments with cells that solely had the 3EG-reactive βΔ4-tubulin, such 
as astrocytes, fibroblasts, or HeLa cells, and observed that microtu-
bule arrangements found in mitotic spindles and midbodies are 
clearly stained by the 3EG antibody (Figure 5A and Supplemental 
Figure S5). Because we clearly observed labeling in these specific 
microtubules structures, we investigated whether the cell cycle 
could regulate the level of C-terminally truncated β variants. How-
ever, HeLa cells synchronized in either G1/S or mitosis showed no 
3EG labeling difference in Western blot experiments (Figure 5B), 
FIGURE 5: The novel β2A/B-tubulin variant βΔ4 evidenced in HeLa cells by 3EG antibody. 
(A) Immunocytochemistry of HeLa cells using 3EG and anti–β-tubulin antibody (βtot). Scale bar: 
10 µm. (B) Immunoblot of protein extracts from nonsynchronized HeLa cells and from HeLa cells 
synchronized in G1/S or mitosis (see Materials and Methods). Cell synchronization was verified 
using a phosphohistone antibody (H3-Ser10P). Loaded proteins were standardized using αtot 
antibody, and the truncated β-tubulin form was analyzed with 3EG antibody. (C) Analysis of the 
β-tubulin band in protein extracts from HEK293T cells expressing GFP- or YFP-tagged CCPs 
(complementary analysis of the experiment in Figure 3A, right, including lower band).
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FIGURE 6: Properties of neuronal 3EG-positive microtubules and tubulins. (A) Immunofluorescence study of the 
distribution of microtubules bearing αΔ3- and βΔ4-tubulin (3EG-positive microtubules) in hippocampal neurons cultured 
2 DIV. Scale bar, 10 µm. Inset, magnification of the growth cone. Distribution of microtubules bearing the other α-tubulin 
variants is shown in Supplemental Figure S6. (B) Time course of nocodazole (20 µM) resistance of microtubules from 2 
DIV hippocampal neurons analyzed in the growth cone (mean ± SEM). Microtubule fluorescence signals were measured 
for a minimum of 31 neurons at each time of drug treatment. The fluorescence signal of each tubulin variant, F(variant), 
was normalized to the total α-tubulin fluorescence signal, F(αtot), which is an index of the remaining microtubules, and 
then was plotted as percentage of the value obtained in the absence of nocodazole (time 0). (C) Immunoblot analysis of 
the distribution of α-tubulin species between soluble (S) and microtubular (MT) fractions in 7 DIV hippocampal neurons 
in the absence (left) or presence of 20 µM nocodazole for 30 min (right). The S and MT protein extracts from neuronal 
cultures (n = 3) were obtained as in Audebert et al. (1993). Results are shown as mean values ± SEM. ***p < 0.001 and 
**p < 0.01, t test. (D) Immunoblot of protein extracted from 7 DIV hippocampal neurons after incubation with DMSO 
(control) or paclitaxel (15 µM) for 2 h.
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process the concerned glutamate residue. The most probable expla-
nation of this discrepancy relates to the tubulin isotype studied. 
Their observation was made on the α4A-tubulin isotype, whereas 
our results were obtained with α1B-tubulin (fused to mCherry). 
Therefore we give here the first indication that CCP deglutamylases 
(in the present case, CCP5) might be selective of the α-tubulin iso-
type for their activity on the primary chain of the protein. This might 
also be the case regarding CCP activity on glutamate side chains.
The second protein reacting with 3EG antibody was identified as 
a novel C-terminally truncated β-tubulin, as shown by both immuno-
precipitation experiments and mass spectrometry analysis. Within 
neonate brains (in which β-tubulin is less polyglutamylated and thus 
easier to analyze), we identified a truncated form of β2A/B-tubulin 
that ends with –EEEG and results from the cleavage of the last four 
amino acids, –EDEA, from the full-length protein encoded by its 
gene. The β2A/B-tubulin isotypes were found in several tissues and 
represent the predominant isotypes in the nervous system, where 
they are expressed in both neurons and glia (Luduena, 2013). The 
newly discovered variant, named βΔ4-tubulin, is present in all mouse 
tissues and cells tested at low level (similar to αΔ3-tubulin, as ob-
served from the intensity of both band signals obtained with 3EG 
antibody; Figures 2A and 4A). Although βΔ4-tubulin can be clearly 
observed by immunofluorescence when concentrated in mitotic 
spindles or midbodies, its level does not vary during the cell cycle. 
Because microtubules are bundling in such mitotic arrangements, 
we cannot distinguish between a specific or nonspecific enrichment 
of the new truncated tubulin variant in these structures.
Although truncation of the α-tubulin C-terminus was discovered 
some time ago and, since then, detyrosination/tyrosination of α-
tubulin has been shown to play a vital role (Erck et al., 2005), very few 
studies have described truncations in the C-terminal region of β-
tubulins. To our knowledge, the work by Miller et al. (2008) is the 
only one describing truncated β-tubulin in mammals. They found 
evidence for the removal of the C-terminal alanine and the penulti-
mate valine residues from β2C-tubulin in rat liver tissue (Miller et al., 
2008). β-Tubulin truncation was also observed in sea urchin. Indeed, 
a large amount (20%) of the β-tubulin from sea urchin sperm flagellar 
axonemes unexpectedly lacks the three carboxy-terminal residues –
EAA encoded by its gene (Multigner et al., 1996). Thus glutamate 
and aspartate, but also alanine and valine, residues appear to be 
cleaved from proteins encoded by β-tubulin genes. Carboxypepti-
dases capable of cleaving acidic residues, deglutamylases and deas-
partylases, were recently discovered (Rogowski et al., 2010; Tort 
et al., 2014). Physiological substrates for deglutamylases, such as 
lateral chains of glutamates on tubulins and other proteins, and C-
termini of α-tubulins have long been known. Our data indicate the 
first physiological substrate for deaspartylases: mammalian β2A/B-
tubulin isotypes. The newly identified truncated variant of β-tubulin 
strongly argues for the existence of other enzymes allowing an in-
creasing range of carboxy-terminal processing. In particular, because 
all of the processed β-tubulins end with an alanine (Multigner et al., 
1996; Miller et al., 2008), dealaninases should very probably exist.
By the use of specific antibodies and a series of mCherry–α-
tubulin isotypes as standards, we estimated the distribution of the 
diverse α-tubulin variants, αTyr, αdeTyr, αΔ2, and αΔ3, in the neo-
nate and adult mouse brain (Figure 2G). For the already known vari-
ants (αTyr, αdeTyr, and αΔ2), our data for adult mouse brain are in 
good agreement with the data obtained by mass spectrometry using 
rat brains (Redeker et al., 1998) and by a separation method using 
the bovine brain (Paturle et al., 1989). In addition, our analyses show 
that the αΔ3 neuronal variant represents only a small portion (∼1%) 
of the total amount of α-tubulin present in the neonate and adult 
(Figure 6C, right). As predicted, acetylated tubulin was recovered in 
the microtubular fraction (97.8%). The same fraction contained 96% 
of the αdeTyr-tubulin, 72.5% of the αΔ2-tubulin, 44.2% of the αΔ3-
tubulin, and 30% of the αTyr-tubulin. Thus αΔ3-tubulin behavior 
under nocodazole treatment is closer to that of labile αTyr-tubulin 
than to that of stable αdeTyr-tubulin. Of interest, αΔ3-tubulin in-
creases and persists in the soluble pool after drug treatment, sug-
gesting irreversible modification within the cytosol.
To further analyze the relationship between microtubule dynam-
ics and tubulin variants in hippocampal neurons, we performed ex-
periments using paclitaxel. Neuron exposure to the stabilizing drug 
(15 μM) for 2 h induces clear changes in the α-tubulin variants: we 
observed a reduction of tyrosinated tubulin and αΔ3-tubulin and an 
accumulation of detyrosinated- and αΔ2-tubulin (Figure 6D). Thus 
the shutdown of tubulin dimer turnover between free tubulin and 
microtubules under paclitaxel exposure induces a loss of αΔ3-
tubulin in cells (see also results in Figure 3E for HEK293T cells ex-
pressing CCP1).
Taken together, our results show that αΔ3-tubulin and βΔ4-
tubulin are essentially found in the microtubular pool of neurons. 
They strongly suggest that microtubular dynamics is required for 
αΔ3-tubulin generation and/or maintenance.
DISCUSSION
In the present study, we developed a novel antibody highly specific 
to C-terminal –EEEG of proteins, which we named 3EG. This anti-
body detected two proteins among all mouse tissues and cells 
tested. We demonstrated that these proteins are novel C-terminally 
truncated variants of α- and β-tubulins.
In the neonate mouse brain, the most abundant of these two 
proteins reacting with 3EG corresponds to α1A/B-tubulin missing its 
last three amino acids. This truncated variant, named αΔ3-tubulin, 
was previously suspected to exist (Berezniuk et al., 2012) because 
CCP1 produced in insect cells is able to generate it in vitro from puri-
fied porcine brain tubulin. Our work demonstrated for the first time 
the physiological existence of αΔ3-tubulin, its restricted presence in 
neuronal cells, and its enrichment in the brain around birth. It has 
been shown that in the adult rat brain, α1A/B-tubulin isotypes con-
stitute ∼85% of the α-tubulin subunit pool (of which 30% are tyros-
inated and 70% are nontyrosinated), whereas isotype α4A repre-
sents 15% (predominantly nontyrosinated; Redeker, 2010). In 
neonates, however, only α1A/B tubulins were detected (Redeker, 
2010). When truncated of three (α1A/B) or two (α4A) amino acids 
(Figure 1C), these brain α-tubulin isotypes all react with 3EG. The 
α1A- and α1B-tubulins are the only isoforms present in the neonate 
brain and are the source of αΔ3-tubulin at this stage. They might also 
be the tubulin isotypes having this modification in adult brains, even 
if a truncation of α4A cannot be excluded. Of interest, a Δ5 form of 
α-tubulin ending with the –EEEG C-terminal sequence was clearly 
revealed by mass spectrometry in Toxoplasma gondii (Xiao et al., 
2010). We tested the ability of the enzymes of the CCP family to 
produce αΔ3-tubulin and αΔ2-tubulin from mCherry–α1B-tubulin fu-
sion protein; the results are summarized in Figure 3E. They are in 
agreement with recent data showing that CCP1 and CCP5 purified 
from sf9-infected cells can catalyze the formation of αΔ3-tubulin 
(Berezniuk et al., 2013). In addition, we show that CCP4 and CCP6 
are also able to cleave αΔ2-tubulin to generate αΔ3-tubulin and that 
CCP2 and CCP3 seem unable to catalyze this reaction. Our results 
are discrepant with those of Berezniuk et al. (2013) concerning the 
effect of CCP5 on the C-terminus of α-tubulin. Indeed, we clearly 
show here that CCP5 is not able to form αΔ2-tubulin from detyros-
inated tubulin, whereas they concluded that this enzyme is able to 
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TTL-knockout mice were first described in Erck et al. (2005) and 
TTLL1-knockout mice in Vogel et al. (2010).
Cell culturing
Hippocampal neurons and murine embryonic fibroblasts (MEFs) 
were prepared as previously described (Erck et al., 2005). Astrocytes 
and cortical neurons were obtained from cerebral cortices of 18-d 
mouse fetuses and MEFs from 13-d mouse fetuses. Adherent 
HEK293T cells were maintained under standard conditions.
For the synchronization protocol, HeLa Kyoto cells were cultured 
in DMEM supplemented with 10% fetal bovine serum. Cells were 
nonsynchronized, synchronized in G1/S using double-thymidine 
block (2 mM), or synchronized in mitosis using either double-thymi-
dine block released for 9 h or nocodazole block (100 ng/ml) released 
for 30 min. Mitotic cells were collected after release by mitotic 
shake-off. Cell extracts were obtained after lysis with buffer contain-
ing 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM ethylene glycol 
tetraacetic acid (EGTA), 1% IGEPAL CA-630, and protease inhibitors 
(Sigma-Aldrich, Taukkirchen, Germany). Protein concentration for 
lysate was determined using Bradford reagent (Sigma-Aldrich).
Antibodies
Primary antibodies used in this study are presented in Supplemen-
tal Table S2. The novel antibody (3EG) was produced in rabbits by 
using peptide C-GEGEEEG (α1A/B-tubulin C-terminus missing 
three amino acids) linked at its N-terminus to the keyhole limpet 
hemocyanin protein via the cysteine. The peptide C-terminus ends 
with COOH. Anti-rabbit, anti-mouse, and anti–guinea pig second-
ary antibodies tagged with either cyanine-5 or cyanine-3 were 
from Jackson ImmunoResearch (Newmarket, United Kingdom), 
and anti-rabbit, anti-mouse, and anti-guinea pig secondary anti-
bodies tagged with horseradish peroxidase (HRP) were from Ma-
cherey Nagel (Hoerdt, France). Mouse TrueBlot ULTRA (anti-mouse 
immunoglobulin G–HRP) was from eBioscience (Paris, France).
Expression constructs and cell transfection
The GFP-CCP expression constructs used in the present study 
were described previously (Peris et al., 2009; Rogowski et al., 
2010; Tort et al., 2014). The α-tubulin variant constructs were gen-
erated by introducing mutations with PCR amplifications between 
the PshAI and BamHI restriction sites of α-tubulin cDNA (mouse 
α1A-tubulin tagged with mCherry; Supplemental Table S3). The 
various PCR products were cloned into templates by using the 
In-Fusion HD Cloning Kit (Ozyme, Montigny, France). All con-
structs were verified by sequence analysis.
Adherent HEK293T cells were transfected with jetPEI transfection 
reagent (Polyplus-Transfection, Illkirch, France). For cotransfections of 
mCherry–α-tubulin with CCPs (Figure 3 and Supplemental Figure S3), 
a 2:1 ratio was used. Murine embryonic fibroblasts were transfected 
using Amaxa Nucleofector kits (Lonza, Basel, Zwitzerland).
Western blotting
For Western blotting, cells were collected after 24 h of transfection 
when transfecting one plasmid and after 48 h when transfecting two 
plasmids. After washing with phosphate-buffered saline (PBS) me-
dium at 37°C, cells were directly lysed in Laemmli buffer. Crude pro-
tein extracts from tissues were obtained by extraction in 100 mM 
1,4-piperazinediethanesulfonic acid at pH 6.7, 1 mM EGTA, 1 mM 
MgCl2, and protease inhibitors (Complete Mini EDTA-free; Roche 
Diagnostics, Meylan, France) using a FastPrep Instrument (MP 
Biomedicals, Illkirch, France). Cell remnants were eliminated by 
brain. It may thus be involved in very specific function(s) of the neu-
ronal microtubules.
Surprisingly, the total amount of α-tubulin found in adults when 
adding all species corresponds to only 41% of the total amount of 
α-tubulin found in neonates. Indeed, we observed a decrease of all 
variants of α-tubulin except αΔ2 between neonate and adult tissue: 
tyrosinated tubulin decreases sevenfold, detyrosinated tubulin by 
30%, and αΔ3 by threefold, whereas αΔ2-tubulin increases about 
sixfold. Two explanations can be considered to explain these results. 
First, some modification might occur in the adult brain (such as lat-
eral polyglutamylation) that disturbs the binding of the α-tubulin C-
terminus antibodies used in the present study (anti-tyrosinated, 
-detyrosinated, -Δ2, -Δ3). In such a case, however, it would be sur-
prising that the level of αΔ2 would still increase as much as six times 
between neonate and adult tissues (Figure 2G). This is also unlikely 
because α-tubulin is already very glutamylated in neonate brains 
(Redeker, 2010) and we showed that polyglutamylation does not 
alter 3EG antibody binding to tubulin (Figure 2H). Thus the second, 
likelier explanation is that other unknown modification(s) of the 
α-tubulin C-terminus might occur in the adult brain and regulate 
C-terminal truncation.
The discovery of two novel C-terminally truncated variants of tu-
bulins and, remarkably a truncated form of β-tubulin increases their 
diversity. These variants of α- and β-tubulins, which end with the 
same amino acids sequence, –EEEG, could share a common specific 
physiological significance. In neurons, αΔ3-tubulin and βΔ4-tubulin 
are essentially found in the microtubular pool. Of interest, αΔ3-
tubulin is present on neuronal microtubules sharing properties with 
tyrosinated microtubules and not with microtubules bearing the 
other truncated α-tubulin species or the acetylated tubulin. Hence 
the neuronal microtubule network appears to be more heteroge-
neous in composition and turnover rate than previously described, 
when only tyrosinated and detyrosinated tubulins were known 
(Schulze et al., 1987; Webster et al., 1987). Although corresponding 
to a modified tubulin, the αΔ3 species seems to be related to dy-
namic microtubules. Microtubule turnover appears to be required for 
its generation and/or maintenance, in contrast to αΔ2-tubulin forma-
tion, which requires stable microtubules. To explain these properties, 
we can speculate that whereas αΔ2-tubulin may be generated by 
CCP enzymes on microtubules, the αΔ3 variant may be formed by 
these enzymes in the cytosol. It is of interest that levels of αΔ3-tubulin 
change with brain age, and it is mainly present before and around 
birth. Thus the αΔ3-tubulin species could have critical function(s) for 
neuronal development, most probably related to highly dynamic mi-
crotubules. The new αΔ3-variant could also confer specific properties 
on neuronal microtubules due to interaction with specific partners.
Deciphering precisely the function(s) of the new physiological 
αΔ3- and βΔ4-tubulin forms will be of crucial importance. This is 
also the case for the abundant neuronal αΔ2-tubulin (Paturle-




In compliance with the European Community Council Directive of 
November 24, 1986 (86/609/EEC), research involving animals was 
authorized by the Direction Départementale de la Protection des 
Populations, Préfecture de l’Isère, France (Permit 380711). Every ef-
fort was made to minimize the number of animals used and their 
suffering. This study was approved by the local ethics committee of 
the Grenoble Institut des Neurosciences. For tissue preparation or 
cell culture, mice were killed and organs were quickly dissected. 
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Immunoprecipitation
Lysates of HEK293T cells were obtained by extraction in 50 mM 
Tris, pH 8.0, 150 mM NaCl, 1 mM MgCl2, and 20 μg/ml DNase 
plus protease inhibitors (Complete Mini EDTA-free, Roche Diag-
nostics, Meylan, France) and 1% NP-40. In the case of neonate 
brains, soluble proteins were first extracted in the same medium 
without detergent using a FastPrep apparatus (MP Biomedicals), 
followed by centrifugation. NP-40 (1%) was added to superna-
tant containing the brain soluble proteins for immunoprecipita-
tion. Lysates were incubated 2 h at 4°C with either anti–α-tubulin 
(αtot) or anti–β-tubulin (βtot) antibodies, followed by 1 h of incu-
bation at 4°C with protein G–Sepharose beads (GE Healthcare). 
Immunoprecipitates were then washed three times with 50 mM 
Tris, pH 8.0, 150 mM NaCl, and 0.2% NP-40 and directly added 
to Laemmli solution for analysis. Analyses of the controls (αtot 
and βtot Western blots) were performed using mouse TrueBlot 
ULTRA.
Mass spectrometry
Sample preparation. The α- and β-tubulins purified from neonate 
brain by a cycle of microtubule assembly and disassembly were 
separated on 10% SDS–PAGE. Protein bands corresponding to β-
tubulins were excised and subjected to in-gel proteolytic digestion 
and proteolytic peptide extraction using the Progest robot (Genomic 
Solutions, Chemsford, MA). Briefly, bands were extensively washed 
with acetonitrile and 25 mM NH4HCO3 and treated with 10 mM 
dithiothreitol (30 min at 56°C) and then 55 mM iodoacetamide 
(30 min at room temperature). Gel slices were then dried and 
incubated with endoproteinase Asp-N (5 ng/μl; Roche Diagnostics) 
for 6 h at 37°C. Proteolytic peptides were extracted (using 60% 
acetonitrile/0.1% formic acid solution, followed by pure acetonitrile), 
vacuum dried, and resuspended in 5% acetonitrile and 0.1% 
trifluoroacetic acid before mass spectrometry analysis.
Nano–liquid chromatography/tandem mass spectrometry 
analysis. Nano–liquid chromatography/tandem mass spectrometry 
(nanoLC-MS/MS) analyses were performed with the LTQ Orbitrap 
Velos mass spectrometer (Thermo Scientific) coupled to the EASY 
nLC II high-performance liquid chromatography system (Proxeon, 
Thermo Scientific, Waltham, MA). Peptide separation was performed 
on a reverse-phase C18 column (100-μm inner diameter, 5-μm C18 
particles, 15-cm length, NTCC-360/100-5) from Nikkyo Technos 
(Tokyo, Japan) with a 5–35% solvent B gradient over 40 min. Solvent 
A was 0.1% formic acid in water, and solvent B was 0.1% formic acid 
in 100% acetonitrile. NanoLC-MS/MS experiments were conducted 
in data-dependent acquisition mode. The 20 most intense ions—
above an intensity threshold of 2000 counts—were selected for CID 
fragmentation and analysis in the LTQ. The m/z values of the 
precursor peptide ions were measured with a high resolution of 
60,000 in the Orbitrap.
Data analysis. NanoLC-MS/MS data were analyzed in two steps. 
First, data were processed automatically using the Mascot search 
engine (version 2.4.1; Matrix Science, London, United Kingdom) in 
Proteome Discoverer 1.4 against the Swissprot database (release 
2014_08), with carbamidomethylation of cysteines as fixed 
modification and oxidation of methionines and glutamylation of 
glutamates as variable modifications. Second, a targeted search 
was conducted against a database composed of all β-tubulin 
isotypes and all possible C-terminal truncated β-tubulin sequences, 
with the same modifications as the first search. Peptide and 
fragment tolerance were respectively set at 10 ppm and 0.6 Da.
10 min of centrifugation at 10,000 × g, and Laemmli buffer was 
added. Proteins were resolved on 10% SDS–PAGE, followed by 
electrotransfer onto Immobilon P sheets (Millipore, St Quentin en 
Yvelines, France). Two commercial SDS preparations were used 
(Sigma-Aldrich L5750 and L4509), with the less pure one allowing 
clear separation of α- and β-tubulins, as previously observed (Best 
et al., 1981). Primary antibodies (Supplemental Table S2) were incu-
bated, and the blots were then stained with secondary antibodies 
coupled to HRP (1:5000), followed by detection by chemilumines-
cence (ECL Western blot Detection Kit; GE Healthcare, Velizy, 
France). The reactive proteins were detected and analyzed using the 
ChemiDoc MP System (Bio-Rad, Dusseldorf, Germany).
For analysis and graphical representations (Figure 2, E and G, 
and Supplemental Table S1), protein bands from immunoblots 
were quantified using ImageJ software (National Institutes of 
Health, Bethesda, MD). After subtraction of the background, rela-
tive detection levels for modification-specific antibodies were de-
termined by adjusting the values to total tubulin levels (measured 
with αtot antibody). To determine the status of modifications in the 
brain (Figure 2G), tissues and HEK293T cells expressing each mod-
ified mCherry-α tubulin were coanalyzed (in the same immuno-
blots; Supplemental Figure S2). This allowed us to determine the 
sensitivity of each modification-specific antibody in the experi-
ment, which is the ratio of signal with modification-specific anti-
body to signal αtot obtained with the corresponding modified 
mCherry-α tubulin. Then signals obtained with tissues extracts 
were normalized to total α tubulin levels (αtot immunoblot of tis-
sues) and to antibody sensitivity in the experiment. We postulated 
that the sum of the four analyzed modifications (αTyr, αdeTyr, αΔ2, 
and αΔ3) represents 100% of α-tubulin in the neonate brain and 
used bar diagrams to plot results as percentages.
Immunocytochemistry
For immunofluorescence, fibroblasts were fixed at 37°C in 4% para-
formaldehyde/4.2% sucrose/PBS, followed by permeabilization in 
0.1% Triton X-100/PBS. Neurons were fixed at 37°C in 4% parafor-
maldehyde, 4% sucrose, 0.25% glutaraldehyde, and 0.1% Triton 
X-100 and incubated in NaBH4/PBS quenching solution. Cells were 
then incubated with primary antibodies (Supplemental Table S2), 
followed by incubation with secondary antibodies conjugated with 
either cyanine-3 or cyanine-5 fluorophores (1:700–1:1000). Nuclei 
were stained using Hoescht 33258 (1 μg/ml).
Immunofluorescence analysis
When analyzing immunocytochemistry experiments (Figure 3D), 
cells were segmented using anti-tyrosinated antibody (YL1/2) signal 
with ImageJ software (Schneider et al., 2012). Cells were classified 
as GFP positive (mean intensity of 8.8 ± 2.1 and 12.3 ± 2.3, respec-
tively, for CCP1 and CCP5) or GFP negative (mean intensity of 
1 ± 0.3). The αΔ3-tubulin content was then expressed as the mean 
intensity staining for 3EG antibody.
When analyzing neuronal microtubule susceptibility to no-
codazole (Figure 6B), the microtubule network was quantified as 
mean fluorescence intensity measured on lines of 5–15 μm long 
placed within growth cone of each neuron. In the three conditions 
(0, 15, and 30 min of nocodazole), 31–60 neurons were analyzed 
for αTyr and αΔ2 and 49–61 neurons were analyzed for αdeTyr and 
3EG. Microtubule fluorescence signal for each variant, F(variant), 
was normalized to αtot signal measured in the same region, 
F(αtot), which is an index of the remaining microtubules), and then 
was plotted (mean ± SEM) as percentage of the value obtained in 
the absence of nocodazole.
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